BESIVANCE Drug Profile, 2024: BESIVANCE (besifloxacin hydrochloride) drug patents, FDA exclusivity, litigation, drug prices

by DrugPatentWatch

BESIVANCE Drug Profile, 2024

This report focuses on BESIVANCE and covers the following critical aspects of this drug:

United States patentsExpired United States patentsClinical trialsDrug pricesAnnual sales revenuesFinished product suppliersRaw active pharmaceutical ingredient (API) sourcesFREE UPDATE: Send your receipt to DrugPatentWatch within 30 days for a free updat

• Format: Paperback
• Language: English
• ISBN: B0CRZ35LSC
• ISBN13: 9798875584176
• Release Date: January 2024
• Publisher: Independently Published
• Length: 42 Pages
• Weight: 0.27 lbs.
• Dimensions: 0.1" x 8.5" x 11.0"